D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

scientific article published in June 2006

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1538-7836.2006.01935.X
P698PubMed publication ID16706961
P5875ResearchGate publication ID7074606

P50authorPaul RidkerQ7153226
Robert J GlynnQ88253834
P2093author name stringCushman M
Bounameaux H
Shrivastava S
Bauer KA
Goldhaber SZ
Kessler CM
Moll S
P2860cites workLong-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismQ34179254
Mutation in blood coagulation factor V associated with resistance to activated protein C.Q34340007
Thrombophilia, clinical factors, and recurrent venous thrombotic eventsQ34419598
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiologyQ35813336
Fibrin fragment D-dimer and the risk of future venous thrombosisQ40625965
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolismQ44548746
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysisQ47351547
High plasma levels of factor VIII and risk of recurrence of venous thromboembolismQ48036239
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophiliaQ57003501
The Long-Term Clinical Course of Acute Deep Venous ThrombosisQ64386235
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosisQ72414738
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyQ73836575
D-dimer levels and risk of recurrent venous thromboembolismQ73864376
High plasma levels of factor VIII and the risk of recurrent venous thromboembolismQ74197149
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based studyQ74208452
P433issue6
P921main subject(RS)-warfarinQ407431
venous thromboembolismQ9397786
P304page(s)1208-1214
P577publication date2006-06-01
P1433published inJournal of Thrombosis and HaemostasisQ6296004
P1476titleD-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
P478volume4

Reverse relations

cites work (P2860)
Q56978729Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence
Q24633053Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Q35987865Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism
Q83363859Can anticoagulant treatment be tailored with biomarkers in patients with venous thromboembolism?
Q53672029Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study.
Q36947358D-dimer level and the risk for thrombosis in systemic lupus erythematosus
Q34418291Disease risk factors identified through shared genetic architecture and electronic medical records
Q57616514Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis
Q38777416Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
Q36063535Epidemiology and risk factors for venous thrombosis
Q38263114How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review
Q33804430Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis
Q37806826Long-term Anticoagulation for Venous Thromboembolism: Duration of Treatment and Management of Warfarin Therapy
Q36718482Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach
Q89468101Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study
Q47959251Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors
Q47923995Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
Q36079864Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study
Q26826847Recurrent venous thromboembolism: what is the risk and how to prevent it
Q34153343Risk assessment for recurrent venous thrombosis
Q30889099Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data
Q34603112Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Q36986116Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis
Q84110126The diagnostic yield of D-Dimer in relation to time from symptom onset in patients evaluated for venous thromboembolism in the emergency medicine department
Q51650332Thrombophilia: 2009 update.
Q38365992Thrombophilia: clinical-practical aspects
Q37419797Unanswered questions in venous thromboembolism
Q84796444Update in general internal medicine
Q51767834Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.